why choose us

First received: April 06, 2023

Clinical Trial: Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Stroke, Acute Ischemic

Study Type: INTERVENTIONAL


Official Title: The Feasibility, Safety and Efficacy of Y-3 Injection Through Skull Bone Marrow Bypassing Blood-brain Barrier in the Treatment of Acute Malignant Middle Cerebral Artery Infarction(SOLUTION)

Brief Summary: The mortality of malignant middle cerebral artery infarction (mMCAI) is up to 80%, while current available treatment is limited.The purpose of this study is to explore the feasibility, safety and efficacy of Intracalvaria bone marrow injection of cytoprotective drug Y-3 in mMCAI patients with contradictions of reperfusion therapy or poor reperfusion outcome.

Read more